Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.

Wood WA, Kumar SK, Semmel EA, James S, Schroeder MA, Chung DJ, Rosenberg A, Zonder J, Rubinstein S, D'Souza A, Martin T, Chari A, Vij R, Nooka AK, Anderson KC, Neuberg DS, Richard S, Torres K, Weiss BM, Pederson L, Derkach A, Geyer S, Usmani SZ

Open source

DOI: 10.1182/bloodadvances.2025018963
Published: 2026 May 12
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025018963,
  title = {Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.},
  author = {Wood WA and Kumar SK and Semmel EA and James S and Schroeder MA and Chung DJ and Rosenberg A and Zonder J and Rubinstein S and D'Souza A and Martin T and Chari A and Vij R and Nooka AK and Anderson KC and Neuberg DS and Richard S and Torres K and Weiss BM and Pederson L and Derkach A and Geyer S and Usmani SZ},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025018963},
  url = {https://doi.org/10.1182/bloodadvances.2025018963}
}

RIS

TY  - JOUR
TI  - Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.
AU  - Wood WA
AU  - Kumar SK
AU  - Semmel EA
AU  - James S
AU  - Schroeder MA
AU  - Chung DJ
AU  - Rosenberg A
AU  - Zonder J
AU  - Rubinstein S
AU  - D'Souza A
AU  - Martin T
AU  - Chari A
AU  - Vij R
AU  - Nooka AK
AU  - Anderson KC
AU  - Neuberg DS
AU  - Richard S
AU  - Torres K
AU  - Weiss BM
AU  - Pederson L
AU  - Derkach A
AU  - Geyer S
AU  - Usmani SZ
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025018963
UR  - https://doi.org/10.1182/bloodadvances.2025018963
ER  -

APA

WA, W., SK, K., EA, S., S, J., MA, S., DJ, C., A, R., J, Z., S, R., A, D., T, M., A, C., R, V., AK, N., KC, A., DS, N., S, R., K, T., BM, W., L, P., A, D., S, G., & SZ, U. (2026). Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.. Blood advances. https://doi.org/10.1182/bloodadvances.2025018963

Source records

pubmed · retrieved 2026-09-27T08:14:38.588Z